DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 8.21

Change

-0.01 (-0.12)%

Market Cap

USD 0.17B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
DRUG:AU
Relative Returns (From:    To: 2025-03-28 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.45% 85% B 69% C-
Dividend Return 0.35% 12% F 7% C-
Total Return 4.80% 86% B+ 69% C-
Trailing 12 Months  
Capital Gain -5.31% 11% F 48% F
Dividend Return 2.89% 42% F 33% F
Total Return -2.42% 11% F 48% F
Trailing 5 Years  
Capital Gain 45.31% 51% F 60% D-
Dividend Return 12.95% 28% F 22% F
Total Return 58.26% 44% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 6.22% 62% D 54% F
Dividend Return 8.04% 61% D- 54% F
Total Return 1.82% 56% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 8.20% 67% D+ 92% A
Risk Adjusted Return 98.10% 88% B+ 95% A
Market Capitalization 0.17B 33% F 65% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.